Kodak Water for Injection (WFI)

Two USP compliant formulations manufactured and aseptically packaged in a cGMP facility located in Rochester, NY.

USP Compliant

Sterile

cGMP Facility

Made in USA

Overview

Kodak Water for Injection (WFI) is produced in a U.S. based, cGMP facility using a multi-step purification process that includes reverse osmosis, continuous deionization, UV disinfection, and distillation. Every lot is produced in compliance with the United States Pharmacopoeia (USP) standard.

Common uses

Bioprocessing
Buffer/media preparation
Washing and rinsing

Not intended for

Diagnostic or therapeutic use
Human administration
Tissue culture media for human ex vivo tissue and cell culture applications

Formulations

Water for Injection (WFI)	Water for Injection (WFI), RNase/DNase/Protease Free
• Endotoxin: < 0.25 EU/mL • Water Type: USP Water for Injection (no additives) • Class: Class 1 Medical Device	• Endotoxin: < 0.25 EU/mL • Water Type: USP Water for Injection (no additives) • Class: Class 1 Medical Device • RNase/DNase/Protease – none detected

Specifications (summary)

Attribute	Specification
Appearance	Clear/Colorless Liquid
Conductivity	< 5µS/cm
Total Organic Carbon	≤ 500 ppb at filling
Endotoxin	< 0.25 EU/mL
pH Distribution	5–7
Sterility	No growth
Operating Conditions	15–38 °C
Storage Conditions	15–30 °C (ambient)
Shelf Life	Shown on label
Packaging	1-liter sterile PETE bottles (recyclable) Bottled and sealed in an aseptically controlled, cGMP environment
Manufacturing Origin	Rochester, NY, USA

Key differences by formulation

WFI vs WFI, RNase/DNase/Protease Free — the R/D/P free variant includes additional testing with "None Detected" results for RNase, DNase, and Protease

Download technical datasheet for complete specifications